Results 191 to 200 of about 75,972 (251)

Microbiological safety and antimicrobial resistance in cashew-based plant-based cheese analogues. [PDF]

Braz J Microbiol
Dalmina NZ, Toigo AL, Krebs KRK, Kothe CI, Mariot RF, Motta H, Kmetzsch L, Suhre T, Klain V, Frazzon APG, Mayer FQ, Frazzon J.   +11 more
europepmc   +1 more source

Fluoroquinolone-Induced Metabolic Dysregulation and Oxidative Stress Orchestrate Bacterial Demise. [PDF]

Microorganisms
Zhou C, Sun J, Luo Y, Wang F, Li L, Wu T, Xie P, Liu C, Hu Y, Sun L, Wang C.   +10 more
europepmc   +1 more source

Adsorptive Removal of Fluoroquinolone Antibiotics Using Bamboo Biochar

Sustainability, 2015
The occurrence of fluoroquinolone antibiotics in wastewater has drawn great attention. Adsorption of widely used fluoroquinolone antibiotics ( enrofloxacin and ofloxacin) in wastewater using bamboo biochar was investigated.
Jian Lu, Yanbin Wang, Jun Wu
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

FLUOROQUINOLONES

Infectious Disease Clinics of North America, 2000
The fluoroquinolone class of antimicrobial agents has expanded dramatically in the last 5 years and will continue to grow over the next decade. This article discusses the newer fluoroquinolones in detail, including pharmacokinetics, pharmacodynamics, safety, and drug interactions, and the spectrum of in vitro activity.
J A, O'Donnell, S P, Gelone
openaire   +3 more sources

The Fluoroquinolones

Mayo Clinic Proceedings, 1991
The fluoroquinolone class of antibiotics promises to become as diverse and as important as beta-lactam agents. The fluoroquinolones inhibit bacterial DNA gyrase and are bactericidal. All fluoroquinolones have potent activity against most gram-negative bacteria; ciprofloxacin is the most active against Pseudomonas aeruginosa.
R C, Walker, A J, Wright
openaire   +2 more sources

Fluoroquinolone Use and Fluoroquinolone Resistance: Is There an Association?

Clinical Infectious Diseases, 1994
In an assessment of potential risk factors for nosocomial infections caused by fluoroquinolone-resistant gram-negative organisms, 68 patients who developed a nosocomial infection caused by a fluoroquinolone-resistant gram-negative bacillus were compared with 191 patients who developed a nosocomial infection caused by a fluoroquinolone-susceptible gram ...
P, Richard, M H, Delangle, D, Merrien, S, Barillé, A, Reynaud, C, Minozzi, H, Richet   +6 more
openaire   +2 more sources

Fluoroquinolones in Paediatrics

Drugs, 1999
Fluoroquinolones have a broad spectrum of activity against gram-positive, gram-negative, and mycobacterial organisms as well as anaerobes, Mycoplasma, Chlamydia, Ureaplasma, and Legionella spp. They have excellent oral bioavailability, with good tissue penetration, and long elimination half-lives. The experience with fluoroquinolones in paediatrics has
H S, Jafri, G H, McCracken
openaire   +2 more sources